Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Matteo Morra
Institution:
University of Verona
Observed institutions:
University of Verona,
Azienda Ospedaliera Universitaria Integrata Verona
ORCID:
0000-0002-1684-0261
Observed ORCID:
0000-0002-1684-0261
OpenAlex ID:
A5038643201
Correlation between gingival phenotype and Schneiderian membrane thickness.
2008
·
Mario Aimetti
, Giampiero Massei
, et al.
·
PubMed
·
128
Host immunological responses facilitate development of SARS-CoV-2 mutations in patients receiving monoclonal antibody treatments
2023
·
Akshita Gupta
, Angelina Konnova
, et al.
·
Journal of Clinical Investigation
·
46
Exploratory data on the clinical efficacy of monoclonal antibodies against SARS-CoV-2 Omicron variant of concern
2022
·
Fulvia Mazzaferri
, Massimo Mirandola
, et al.
·
eLife
·
26
Gut Microbiome Disruption Following SARS-CoV-2: A Review
2024
·
Elda Righi
, Ilaria Dalla Vecchia
, et al.
·
Microorganisms
·
23
PDF
The Emerging Resistance Index: tracking early resistance to new antibiotics
2025
·
Jacopo Garlasco
, Fabiana Arieti
, et al.
·
The Lancet Infectious Diseases
·
14
Clinical efficacy of different monoclonal antibody regimens among non-hospitalised patients with mild to moderate COVID-19 at high risk for disease progression: a prospective cohort study
2022
·
Alessia Savoldi
, Matteo Morra
, et al.
·
European Journal of Clinical Microbiology & Infectious Diseases
·
10
Diagnostic Accuracy of a Rapid SARS-CoV-2 Antigen Test Among People Experiencing Homelessness: A Prospective Cohort and Implementation Study
2023
·
Pasquale De Nardo
, Maela Tebon
, et al.
·
Infectious Diseases and Therapy
·
4
PDF
Author response: Exploratory data on the clinical efficacy of monoclonal antibodies against SARS-CoV-2 Omicron variant of concern
2022
·
Fulvia Mazzaferri
, Massimo Mirandola
, et al.
·
eLife
·
4
Clinical Impact of Monoclonal Antibodies in the Treatment of High-Risk Patients with SARS-CoV-2 Breakthrough Infections: The ORCHESTRA Prospective Cohort Study
2022
·
Alessia Savoldi
, Matteo Morra
, et al.
·
Biomedicines
·
3
PDF
Acceptability of Switching to Long-Acting Cabotegravir and Rilpivirine Among People Living with HIV on Dolutegravir/Rilpivirine Combination: A Single-Center Experience
2023
·
Alessandro Castelli
, Massimiliano Lanzafame
, et al.
·
AIDS Research and Human Retroviruses
·
2
Latent transition analysis for longitudinal studies of post-acute infection syndromes
2026
·
Roy Gusinow
, Anna Górska
, et al.
·
Nature Communications
·
1
Exploring the evidence for use of cefiderocol as part of combination therapies: A systematic review of in vitro, in vivo, and clinical studies
2026
·
Marco Meroi
, Juan Antonio del Castillo Polo
, et al.
·
Journal of Global Antimicrobial Resistance
Show more works
View as search
Works count:
12
Citation count:
261
H-index:
6
I10-index:
6
Year
Topic
Type